the Efficacy of Hyperbaric Oxygen on Acute Ankle Sprain
A Multicenter, Prospective Clinical Randomized Controlled Study of the Efficacy of Hyperbaric Oxygen on Acute Ankle Sprain
1 other identifier
interventional
208
0 countries
N/A
Brief Summary
Investigators recruited 208 patients with acute ankle sprain who were from the Rehabilitation Department of the Second Affiliated Hospital of Zhejiang University, School of Medicine from January 2026 to November 2028. Perform the improvement in AOFAS scores and Baird-Jackson ankle scores study and Rehabilitation assessments followed up after 3 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2026
CompletedFirst Posted
Study publicly available on registry
February 12, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2029
February 12, 2026
January 1, 2026
3 years
January 20, 2026
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
AOFAS score
Improvement of American Orthopaedic Foot \& Ankle Society Score (AOFAS scores)in acute ankle sprains with early HBO treatment. Usually scored from 0 to 100, higher scores mean a better outcome.
3 years
Baird-Jackson ankle score
Improvement of Baird-Jackson Ankle Evaluation Score(Baird-Jackson ankle scores) in acute ankle sprains with early HBO treatment. Usually scored from 0 to 100., higher scores mean a better outcome.
3 years
Secondary Outcomes (6)
pain scores
3 years
ankle swelling
3 years
high-frequency ultrasound findings
3 years
Ankle MRI
3 years
patient's overall evaluation of treatment (PGIC)
3 years
- +1 more secondary outcomes
Study Arms (2)
hyperbaric oxygen group
EXPERIMENTALThe treatment is administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation.
non hyperbaric oxygen group
SHAM COMPARATORThe treatment is administered at an atmospheric pressure of 1.4 ATA with an inhaled oxygen fraction of 21%
Interventions
The treatment is administered at an atmospheric pressure of 2 ATA, with 100% oxygen inhalation. Oxygen inhalation time: 40 minutes (inhaling oxygen for 20 minutes, resting for 5 minutes, inhaling oxygen for 20 minutes, decompression), once daily, for 14 consecutive days. (Commenced immediately after randomisation)
The treatment is administered at an atmospheric pressure of 1.4 ATA with an inhaled oxygen fraction of 21%, oxygen inhalation time: 40 minutes (20 minutes of oxygen inhalation, 5 minutes rest, 20 minutes of oxygen inhalation, decompression), once daily, for 14 consecutive days. (Commences immediately after randomisation)
Eligibility Criteria
You may qualify if:
- Unilateral ankle sprain;
- Swelling, bruising, and pain at the site of the sprain;
- Injury occurring within 72 hours;
- MRI examination clearly shows ligament damage.
You may not qualify if:
- X-ray shows ankle fracture;
- Ankle has skin lesions or skin diseases;
- History of lower limb and pelvic surgery;
- Obvious neurological or psychiatric disorders that may interfere with assessment;
- Severe ligament injuries or joint instability requiring surgical treatment;
- Previous ankle injuries, persistent pain or functional limitations;
- Pneumothorax, severe emphysema, active bleeding, or other diseases with contraindications for hyperbaric oxygen therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bing Xiong
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2026
First Posted
February 12, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
March 1, 2029
Study Completion (Estimated)
March 1, 2029
Last Updated
February 12, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share